2026-01-15 - Analysis Report
**Report for GE Vernova (GEV)**

**Company Overview**
Unknown Company

**Return Rate Comparison**
- Review Stock (GEV): 76.45%
- Comparison Stock (VOO): 32.90%
- Divergence: 43.55%

**SMA Fluctuations**
- Close: $644.18
- 5-day SMA: $637.39
- 20-day SMA: $656.24
- 60-day SMA: $614.77

**Index Analysis**
- MRI: 0.70 (Medium Investment)
- RSI: 44.38
- PPO: -0.83
- Hybrid Signal: Buy (Cash 0%)
  - Recent (20 days) relative divergence change: -6.40 (worsening)
  - 7-day Rank change: 0 (flat)
  - 7-day Dynamic Expected Return change: 0.00 (flat)
  - Expected Return: N/A%

**Recent News & Significant Events**
- Positive news articles from major financial publications (no specific content printed)

**Analyst Opinions**
- Analyst Consensus:
  - Key: Buy
  - Mean (1=StrongBuy~5=Sell): 1.87 (~Buy)
  - Opinions: 27
  - Target Price (avg/high/low): 753.66 / 1000.00 / 500.00

**Earnings Analysis**
| Date | EPS | Revenue |
|----------|--------|---------|
| 2025-11-10 | -0.03 | $0.04 B$ |
| 2025-08-11 | 0.01 | $0.04 B$ |
| 2025-05-13 | -0.09 | $0.03 B$ |
| 2024-11-07 | -0.09 | $0.00 B$ |
| 2025-11-10 | -0.09 | $0.00 B$ |

**Financial Information**
### Revenue and Profitability
| Quarter | Revenue | Profit Margin |
|---------|----------|---------------|
| 2025-09-30 | $9.97B | 19.04% |
| 2025-06-30 | $9.11B | 20.26% |
| 2025-03-31 | $8.03B | 18.30% |
| 2024-12-31 | $10.56B | 20.11% |
| 2024-09-30 | $8.91B | 12.44% |

### Capital and Profitability
| Quarter | Equity | ROE |
|---------|---------|-----|
| 2025-09-30 | $8.65B | 5.23% |
| 2025-06-30 | $8.88B | 5.79% |
| 2025-03-31 | $8.61B | 2.95% |
| 2024-12-31 | $9.55B | 5.07% |
| 2024-09-30 | $9.50B | -1.01% |

**Comprehensive Analysis**
- Return rate comparison indicates GEV has a higher return rate than VOO as of the last available data.
- SMA fluctuations indicate a short-term decline.
- Index analysis indicates a medium risk level, with RSI below 50 and PPO negative.
- Analyst opinions are generally positive with a 'buy' recommendation.
- Quarterly data shows mixed performance in earnings and revenue.
- Financial information indicates a decline in profit margin in some quarters and a positive equity.

**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.